Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03305588 · ClinicalTrials.gov registry record · NA

RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease

A NA study of Parkinson Disease and Essential Tremor, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03305588 is a NA study of Parkinson Disease and Essential Tremor that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 40 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03305588, a NA study of Parkinson Disease and Essential Tremor, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

To determine the efficacy of frameless Virtual Cone Radiosurgical Thalamotomy for medically refractory tremor resulting from either Essential Tremor or Tremor-Dominant Parkinson's Disease with the Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS) in patients who are not candidates for deep brain stimulation (DBS).

Interventions

  • DEVICE Unframed Virtual Cone

Study Locations (1)

Alabama

  • University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center - Birmingham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2017-12-05
Est. Completion 2026-09-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03305588

The ClinicalTrials.gov registry entry for NCT03305588 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Unframed Virtual Cone is the first listed.

NCT03305588 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03305588 about?

NCT03305588 is a clinical study titled "RAD 1601: EDGE Radiosurgery for Intractable Essential Tremor and Tremor-Dominant Parkinson's Disease". To determine the efficacy of frameless Virtual Cone Radiosurgical Thalamotomy for medically refractory tremor resulting from either Essential Tremor or Tremor-Dominant Parkinson's Disease with the Fahn-Tolosa-Marin Tremor Rating Scale (FTMTRS) in patients who are not candidates for deep brain stimul...

What is the current status of trial NCT03305588?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2017-12-05. Estimated completion is 2026-09-01.

What conditions does trial NCT03305588 study?

This clinical trial studies the following conditions: Parkinson Disease, Essential Tremor.

What interventions are being tested in trial NCT03305588?

The interventions under investigation include: Unframed Virtual Cone (DEVICE).

Who is sponsoring clinical trial NCT03305588?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03305588 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.